search button
Open Access

MicroRNA-155 acts as a tumor suppressor in colorectal cancer by targeting CTHRC1 in vitro

  • Authors:
    • Jingtian Liu
    • Zongyou Chen
    • Jianbin Xiang
    • Xiaodong Gu

  • View Affiliations

  • Published online on: February 16, 2018     https://doi.org/10.3892/ol.2018.8069
  • Pages: 5561-5568

  • Copyright: © Liu et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Colorectal cancer is one of the most common malignancies. Aberrant expressed microRNAs (miRNAs) have been demonstrated to have strong associations with colorectal cancer by repressing their targets. Therefore, miRNAs are thought to have significant promise in the diagnosis and prognosis of colorectal cancer. Previous studies indicated that miR‑155 and collagen triple helix repeat containing 1 (CTHRC1) were both involved in pathogenesis of colorectal cancer, but the underlying mechanisms of miR‑155 and CTHRC1 are still unknown. The present study aimed to investigate the biological functions of miR‑155 and CTHRC1 in colorectal cancer. Reverse transcription‑quantitative polymerase chain reaction was used to examine miR‑155 and CTHRC1 expression levels. A dual‑luciferase reporter assay was applied to verify the target interaction between miR‑155 and CTHRC1. Proliferation, cell cycle, apoptosis, cell migration and invasion were measured using the MTT assay, flow cytometry and Transwell assays, respectively. Results showed that miR‑155 expression was decreased, but CTHRC1 expression was increased in colorectal cancer tissue and cell lines. Furthermore, it was demonstrated that miR‑155 negatively regulated CTHRC1. Additionally, miR‑155 overexpression suppressed cell proliferation, induced cell cycle arrest and promoted cell apoptosis, while an inhibitor of miR‑155 facilitated cell proliferation and cell cycle and repressed apoptosis. Transwell experiments indicated that miR‑155 inhibited the cell migratory and invasive abilities of HT‑29 cells, but miR‑155 inhibitor enhanced these abilities of HT‑29 cells. These results suggested that miR‑155 prevented colorectal cancer progression and metastasis via silencing CTHRC1 in vitro, which provides evidence for miR‑155 and CTHRC1 as a novel anti‑onco molecular target for the treatment of colorectal cancer in the future.
View Figures
View References

Related Articles

Journal Cover

April-2018
Volume 15 Issue 4

Print ISSN: 1792-1074
Online ISSN:1792-1082

Sign up for eToc alerts

Recommend to Library

  • Journal Metrics
  • Impact Factor: 2.5
  • Ranked Oncology
    (total number of cites)
  • CiteScore: 5.7
  • CiteScore Rank: Q2: #139/404 Oncology
  • Source Normalized Impact per Paper (SNIP): 0.574
  • SCImago Journal Rank (SJR): 0.644
International Symposium on Molecular Medicine Conference Banner
The Cancer Story
World Congress on Advances in Oncology and International Symposium on Molecular Medicine Conference Banner
World Academy Of Sciences Banner
Heyday Road Banner

0

Copy and paste a formatted citation
x
Spandidos Publications style
Liu J, Chen Z, Xiang J and Gu X: MicroRNA-155 acts as a tumor suppressor in colorectal cancer by targeting CTHRC1 in vitro. Oncol Lett 15: 5561-5568, 2018.
APA
Liu, J., Chen, Z., Xiang, J., & Gu, X. (2018). MicroRNA-155 acts as a tumor suppressor in colorectal cancer by targeting CTHRC1 in vitro. Oncology Letters, 15, 5561-5568. https://doi.org/10.3892/ol.2018.8069
MLA
Liu, J., Chen, Z., Xiang, J., Gu, X."MicroRNA-155 acts as a tumor suppressor in colorectal cancer by targeting CTHRC1 in vitro". Oncology Letters 15.4 (2018): 5561-5568.
Chicago
Liu, J., Chen, Z., Xiang, J., Gu, X."MicroRNA-155 acts as a tumor suppressor in colorectal cancer by targeting CTHRC1 in vitro". Oncology Letters 15, no. 4 (2018): 5561-5568. https://doi.org/10.3892/ol.2018.8069